Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.

Identifieur interne : 000D77 ( PubMed/Checkpoint ); précédent : 000D76; suivant : 000D78

Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.

Auteurs : D B Borson ; J J Brokaw ; K. Sekizawa ; D M Mcdonald ; J A Nadel

Source :

RBID : pubmed:2545662

Descripteurs français

English descriptors

Abstract

Neuropeptides such as substance P are implicated in inflammation mediated by sensory nerves (neurogenic inflammation), but the roles in disease of these peptides and the peptidases that degrade them are not understood. It is well established that inflammation is a prominent feature of several airway diseases, including viral infections, asthma, bronchitis, and cystic fibrosis. These diseases are characterized by cough, airway edema, and abnormal secretory and bronchoconstrictor responses, all of which can be elicited by substance P. The effects of substance P and other peptides that may be involved in inflammation are decreased by endogenous neutral endopeptidase (NEP; also called enkephalinase, EC 3.4.24.11), which is a peptidase that degrades substance P and other peptides. In the present study, we report that rats with histories of infections caused by common respiratory tract pathogens (parainfluenza virus type 1, rat corona-virus, and Mycoplasma pulmonis) not only have greater susceptibility to neurogenic inflammatory responses than do pathogen-free rats but also have a lower activity of NEP in the trachea. This reduction in NEP activity may cause the increased susceptibility to neurogenic inflammation by allowing higher concentrations of substance P to reach tachykinin receptors in the trachea. Thus decreased NEP activity may exacerbate some of the pathological responses in animals with respiratory tract infections.

DOI: 10.1152/jappl.1989.66.6.2653
PubMed: 2545662


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:2545662

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.</title>
<author>
<name sortKey="Borson, D B" sort="Borson, D B" uniqKey="Borson D" first="D B" last="Borson">D B Borson</name>
<affiliation>
<nlm:affiliation>Cardiovascular Research Institute, University of California, San Francisco 94143-0130.</nlm:affiliation>
<wicri:noCountry code="subField">San Francisco 94143-0130</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Brokaw, J J" sort="Brokaw, J J" uniqKey="Brokaw J" first="J J" last="Brokaw">J J Brokaw</name>
</author>
<author>
<name sortKey="Sekizawa, K" sort="Sekizawa, K" uniqKey="Sekizawa K" first="K" last="Sekizawa">K. Sekizawa</name>
</author>
<author>
<name sortKey="Mcdonald, D M" sort="Mcdonald, D M" uniqKey="Mcdonald D" first="D M" last="Mcdonald">D M Mcdonald</name>
</author>
<author>
<name sortKey="Nadel, J A" sort="Nadel, J A" uniqKey="Nadel J" first="J A" last="Nadel">J A Nadel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2545662</idno>
<idno type="pmid">2545662</idno>
<idno type="doi">10.1152/jappl.1989.66.6.2653</idno>
<idno type="wicri:Area/PubMed/Corpus">000D97</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D97</idno>
<idno type="wicri:Area/PubMed/Curation">000D97</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D97</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D77</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D77</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.</title>
<author>
<name sortKey="Borson, D B" sort="Borson, D B" uniqKey="Borson D" first="D B" last="Borson">D B Borson</name>
<affiliation>
<nlm:affiliation>Cardiovascular Research Institute, University of California, San Francisco 94143-0130.</nlm:affiliation>
<wicri:noCountry code="subField">San Francisco 94143-0130</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Brokaw, J J" sort="Brokaw, J J" uniqKey="Brokaw J" first="J J" last="Brokaw">J J Brokaw</name>
</author>
<author>
<name sortKey="Sekizawa, K" sort="Sekizawa, K" uniqKey="Sekizawa K" first="K" last="Sekizawa">K. Sekizawa</name>
</author>
<author>
<name sortKey="Mcdonald, D M" sort="Mcdonald, D M" uniqKey="Mcdonald D" first="D M" last="Mcdonald">D M Mcdonald</name>
</author>
<author>
<name sortKey="Nadel, J A" sort="Nadel, J A" uniqKey="Nadel J" first="J A" last="Nadel">J A Nadel</name>
</author>
</analytic>
<series>
<title level="j">Journal of applied physiology (Bethesda, Md. : 1985)</title>
<idno type="ISSN">8750-7587</idno>
<imprint>
<date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Capillary Permeability</term>
<term>Coronaviridae Infections (enzymology)</term>
<term>Coronaviridae Infections (physiopathology)</term>
<term>Female</term>
<term>Mycoplasma Infections (enzymology)</term>
<term>Mycoplasma Infections (physiopathology)</term>
<term>Neprilysin (metabolism)</term>
<term>Parainfluenza Virus 1, Human</term>
<term>Paramyxoviridae Infections (enzymology)</term>
<term>Paramyxoviridae Infections (physiopathology)</term>
<term>Rats</term>
<term>Respiratory Tract Infections (enzymology)</term>
<term>Respiratory Tract Infections (physiopathology)</term>
<term>Trachea (enzymology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Infections de l'appareil respiratoire (enzymologie)</term>
<term>Infections de l'appareil respiratoire (physiopathologie)</term>
<term>Infections à Coronaviridae (enzymologie)</term>
<term>Infections à Coronaviridae (physiopathologie)</term>
<term>Infections à Mycoplasma (enzymologie)</term>
<term>Infections à Mycoplasma (physiopathologie)</term>
<term>Infections à Paramyxoviridae (enzymologie)</term>
<term>Infections à Paramyxoviridae (physiopathologie)</term>
<term>Néprilysine (métabolisme)</term>
<term>Perméabilité capillaire</term>
<term>Rats</term>
<term>Trachée (enzymologie)</term>
<term>Virus parainfluenza humain de type 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Neprilysin</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Coronaviridae</term>
<term>Infections à Mycoplasma</term>
<term>Infections à Paramyxoviridae</term>
<term>Trachée</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Coronaviridae Infections</term>
<term>Mycoplasma Infections</term>
<term>Paramyxoviridae Infections</term>
<term>Respiratory Tract Infections</term>
<term>Trachea</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Néprilysine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Coronaviridae</term>
<term>Infections à Mycoplasma</term>
<term>Infections à Paramyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Coronaviridae Infections</term>
<term>Mycoplasma Infections</term>
<term>Paramyxoviridae Infections</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Capillary Permeability</term>
<term>Female</term>
<term>Parainfluenza Virus 1, Human</term>
<term>Rats</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Perméabilité capillaire</term>
<term>Rats</term>
<term>Virus parainfluenza humain de type 1</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Neuropeptides such as substance P are implicated in inflammation mediated by sensory nerves (neurogenic inflammation), but the roles in disease of these peptides and the peptidases that degrade them are not understood. It is well established that inflammation is a prominent feature of several airway diseases, including viral infections, asthma, bronchitis, and cystic fibrosis. These diseases are characterized by cough, airway edema, and abnormal secretory and bronchoconstrictor responses, all of which can be elicited by substance P. The effects of substance P and other peptides that may be involved in inflammation are decreased by endogenous neutral endopeptidase (NEP; also called enkephalinase, EC 3.4.24.11), which is a peptidase that degrades substance P and other peptides. In the present study, we report that rats with histories of infections caused by common respiratory tract pathogens (parainfluenza virus type 1, rat corona-virus, and Mycoplasma pulmonis) not only have greater susceptibility to neurogenic inflammatory responses than do pathogen-free rats but also have a lower activity of NEP in the trachea. This reduction in NEP activity may cause the increased susceptibility to neurogenic inflammation by allowing higher concentrations of substance P to reach tachykinin receptors in the trachea. Thus decreased NEP activity may exacerbate some of the pathological responses in animals with respiratory tract infections.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">2545662</PMID>
<DateCompleted>
<Year>1989</Year>
<Month>08</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>12</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">8750-7587</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>66</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1989</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of applied physiology (Bethesda, Md. : 1985)</Title>
<ISOAbbreviation>J. Appl. Physiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.</ArticleTitle>
<Pagination>
<MedlinePgn>2653-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Neuropeptides such as substance P are implicated in inflammation mediated by sensory nerves (neurogenic inflammation), but the roles in disease of these peptides and the peptidases that degrade them are not understood. It is well established that inflammation is a prominent feature of several airway diseases, including viral infections, asthma, bronchitis, and cystic fibrosis. These diseases are characterized by cough, airway edema, and abnormal secretory and bronchoconstrictor responses, all of which can be elicited by substance P. The effects of substance P and other peptides that may be involved in inflammation are decreased by endogenous neutral endopeptidase (NEP; also called enkephalinase, EC 3.4.24.11), which is a peptidase that degrades substance P and other peptides. In the present study, we report that rats with histories of infections caused by common respiratory tract pathogens (parainfluenza virus type 1, rat corona-virus, and Mycoplasma pulmonis) not only have greater susceptibility to neurogenic inflammatory responses than do pathogen-free rats but also have a lower activity of NEP in the trachea. This reduction in NEP activity may cause the increased susceptibility to neurogenic inflammation by allowing higher concentrations of substance P to reach tachykinin receptors in the trachea. Thus decreased NEP activity may exacerbate some of the pathological responses in animals with respiratory tract infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Borson</LastName>
<ForeName>D B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo>
<Affiliation>Cardiovascular Research Institute, University of California, San Francisco 94143-0130.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brokaw</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sekizawa</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McDonald</LastName>
<ForeName>D M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nadel</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HL-24136</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL-38947</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R0-149-1</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Appl Physiol (1985)</MedlineTA>
<NlmUniqueID>8502536</NlmUniqueID>
<ISSNLinking>0161-7567</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.4.24.11</RegistryNumber>
<NameOfSubstance UI="D015260">Neprilysin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002199" MajorTopicYN="N">Capillary Permeability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009175" MajorTopicYN="N">Mycoplasma Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015260" MajorTopicYN="N">Neprilysin</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010222" MajorTopicYN="N">Parainfluenza Virus 1, Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014132" MajorTopicYN="N">Trachea</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1989</Year>
<Month>6</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1989</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1989</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">2545662</ArticleId>
<ArticleId IdType="doi">10.1152/jappl.1989.66.6.2653</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Borson, D B" sort="Borson, D B" uniqKey="Borson D" first="D B" last="Borson">D B Borson</name>
<name sortKey="Brokaw, J J" sort="Brokaw, J J" uniqKey="Brokaw J" first="J J" last="Brokaw">J J Brokaw</name>
<name sortKey="Mcdonald, D M" sort="Mcdonald, D M" uniqKey="Mcdonald D" first="D M" last="Mcdonald">D M Mcdonald</name>
<name sortKey="Nadel, J A" sort="Nadel, J A" uniqKey="Nadel J" first="J A" last="Nadel">J A Nadel</name>
<name sortKey="Sekizawa, K" sort="Sekizawa, K" uniqKey="Sekizawa K" first="K" last="Sekizawa">K. Sekizawa</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D77 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000D77 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:2545662
   |texte=   Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:2545662" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021